Finance

Lists
METX:CNSX
ME Therapeutics Holdings Inc
1,80 CA$
0,00%
(0,00) 1D
15 қаз., 09:31:16 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for METX...
Mkt. cap
54,70 млн
Avg. vol.
673,00
Volume
50,00
52-wk high
8,00 CA$
52-wk low
0,79 CA$
EPS
-0,05 CA$
Mkt. cap
54,70 млн
Avg. vol.
673,00
Volume
50,00
52-wk high
8,00 CA$
52-wk low
0,79 CA$
EPS
-0,05 CA$
News stories
From web sources and news partners
About ME Therapeutics Holdings Inc
CEO-
Employees-
Founded2014
HeadquartersВанкувер, Британдық Колумбия, Канада
Sector-
Websitemetherapeutics.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 ж. там.
2025 ж. қар.
2026 ж. ақп.
2026 ж. мам.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
165,08 м.
141,84 м.
178,41 м.
245,32 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
209,58 м.
213,56 м.
124,66 м.
163,76 м.
Operating expense
401,22 м.
381,91 м.
331,36 м.
436,48 м.
Total operating expenses
401,22 м.
381,91 м.
331,36 м.
436,48 м.
Operating income
-401,22 м.
-381,91 м.
-331,36 м.
-436,48 м.
Other non operating income
57,29 мың
23,69 мың
39,50 мың
35,46 мың
EBT including unusual items
-338,41 м.
-354,43 м.
-289,22 м.
-398,35 м.
EBT excluding unusual items
-338,41 м.
-354,43 м.
-289,22 м.
-398,35 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-338,41 м.
-354,43 м.
-289,22 м.
-398,35 м.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
8,34 мың
6,10 мың
4,39 мың
3,87 мың
Interest expense
-2,82 мың
-2,31 мың
-1,76 мың
-1,20 мың
Net interest expenses
5,52 мың
3,79 мың
2,63 мың
2,68 мың
Depreciation and amortization charges
26,56 мың
26,52 мың
28,28 мың
27,40 мың
EBITDA
-388,82 м.
-369,59 м.
-317,26 м.
-423,28 м.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары